Rallybio Corporation
RLYB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $41,803 | $96,669 | $209,066 | $306,520 |
| - Cash | $13,903 | $24,494 | $56,958 | $175,334 |
| + Debt | $154 | $392 | $555 | $0 |
| Enterprise Value | $28,054 | $72,567 | $152,663 | $131,186 |
| Revenue | $636 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $636 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$60,365 | -$78,782 | -$67,717 | -$45,389 |
| % Margin | -9,491.4% | – | – | – |
| Net Income | -$57,775 | -$74,564 | -$66,654 | -$47,013 |
| % Margin | -9,084.1% | – | – | – |
| EPS Diluted | -1.33 | -1.84 | -2.09 | -1.46 |
| % Growth | 27.7% | 12% | -43.2% | – |
| Operating Cash Flow | -$49,282 | -$60,265 | -$57,284 | -$45,533 |
| Capital Expenditures | $0 | -$12 | -$54 | -$333 |
| Free Cash Flow | -$49,282 | -$60,277 | -$57,338 | -$45,866 |